We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant

19 hedge funds and large institutions have $1.2M invested in TriSalus Life Sciences Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more capital invested

Capital invested by funds: $160K → $1.2M (+$1.04M)

17% less funds holding

Funds holding: 2319 (-4)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
3
Closed
6
Calls
$588K
Puts
Net Calls
+$588K
Net Calls Change
-$918K
Name Holding Trade Value Shares
Change
Change in
Stake
MF
1
Magnetar Financial
Illinois
$331K -$70.8K -329,993 -27%
HCM
2
Highbridge Capital Management
New York
$137K
DM
3
Deerfield Management
New York
$127K
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$109K
ETH
5
Exos TFP Holdings
New York
$63.7K
KL
6
KIM LLC
Kansas
$63K
VI
7
Vestcor Inc
New Brunswick, Canada
$56K
MP
8
MSD Partners
New York
$50.7K
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$50.7K
Walleye Capital
10
Walleye Capital
New York
$39.7K
BCL
11
Bracebridge Capital LLC
Massachusetts
$37.6K
SCM
12
Shaolin Capital Management
Florida
$29K +$16.6K +77,164 New
CCM
13
Context Capital Management
California
$27K
SFA
14
Sequoia Financial Advisors
Ohio
$23.6K
CF
15
Cantor Fitzgerald
New York
$23.4K
CM
16
CastleKnight Management
New York
$17.4K
HF
17
HRT Financial
New York
$11K -$24 -110 -0.4%
Jane Street
18
Jane Street
New York
$6.56K -$2 -7 -0%
TRCT
19
Tower Research Capital (TRC)
New York
$16 +$9 +42 New
KC
20
Kepos Capital
New York
-$7K -145,000 Closed
RCM
21
Radcliffe Capital Management
Pennsylvania
-$6.67K -138,194 Closed
AA
22
AQR Arbitrage
Connecticut
-$2.79K -66,665 Closed
FTUS
23
Flow Traders U.S.
New York
-$1K -17,255 Closed
FSI
24
Flow State Investments
Illinois
-$426 -10,162 Closed
CS
25
Clear Street
New York
-$4 -102 Closed

TLSIW Hedge Fund Activity: Q3 2023 in Review

19 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2023, worth a combined $1.2M — up 650% from $160K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TLSIW and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $16.6K. The largest seller was Magnetar Financial, cutting an estimated $70.8K.

  • 19 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2023, down from 23 in Q2 2023.
  • Funds reported $1.2M of TriSalus Life Sciences Warrant stock for Q3 2023, up 650% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q3 2023 and 6 closed out, a net change of -4 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2023 was Shaolin Capital Management, an estimated $16.6K added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2023 was Magnetar Financial, an estimated $70.8K sold.

Based on aggregated 13F filings for Q3 2023.